Arexis AB
This article was originally published in Start Up
Executive Summary
Arexis is using specially designed animal models to unravel the genetics of metabolic disease.
You may also be interested in...
CliniGenetics SA
French start-up CliniGenetics SA has devised an integrated pharmacogenomics and bioinformatics technology platform to identify gene and protein targets associated with vascular diseases. The company hopes to use those targets to devise novel therapies and diagnostics.
Tackling Diabetes and Obesity
The growing incidence of these diseases, and their complexity, provide opportunities for a number of different approaches
Radiopharmaceuticals: A New Frontier In Precision Cancer Therapy
Growing interest in radioligand-based cancer therapies reflects the class’s unique advantages – including the ability to “see what you treat.”